The role of interventional radiology for the treatment of hepatic metastases from neuroendocrine tumor: an updated review

M Barat, AS Cottereau, A Kedra, S Dermine… - Journal of clinical …, 2020 - mdpi.com
Interventional radiology plays an important role in the management of patients with
neuroendocrine tumor liver metastasis (NELM). Transarterial embolization (TAE) …

Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors

M Ronot, MD Burgio, J Gregory, O Hentic… - Best Practice & …, 2023 - Elsevier
Neuroendocrine tumors (NETs) are relatively rare neoplasms displaying heterogeneous
clinical behavior, ranging from indolent to aggressive forms. Patients diagnosed with NETs …

The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine …

R Hayoz, N Vietti-Violi, R Duran, JF Knebel… - European …, 2020 - Springer
Objectives To compare the diagnostic accuracy of dynamic contrast-enhanced phases,
hepatobiliary phase (HBP), and diffusion-weighted imaging (DWI) for the detection of liver …

[HTML][HTML] Identification of CD206 as a potential biomarker of cancer stem‑like cells and therapeutic agent in liver cancer

W Fan, X Yang, F Huang, X Tong… - Oncology …, 2019 - spandidos-publications.com
The mannose receptor (CD206) functions in endocytosis and phagocytosis, and plays an
important role in immune homeostasis. Tumor‑associated macrophages express high level …

Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver …

M Ingenerf, C Auernhammer, R Lorbeer… - Radiology and …, 2024 - sciendo.com
Utility of clinical and MR imaging parameters for prediction and monitoring of response to
capecitabine and temozolomide (CAPTEM Page 1 Radiology and Oncology | Ljubljana …

Imaging neuroendocrine tumors: Characterizing the spectrum of radiographic findings

A Baghdadi, M Ghadimi, S Mirpour, B Hazhirkarzar… - Surgical Oncology, 2021 - Elsevier
Neuroendocrine tumors (NET) are a group of neoplasms with neuroendocrine differentiation
affecting a wide range of organs. Functional NETs present with symptoms due to the …

[HTML][HTML] Synchronous neuroendocine liver metastases in comparison to primary pancreatic neuroendocrine tumors on MRI and SSR-PET/CT

A Horng, M Ingenerf, F Berger, D Steffinger… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Background The study aimed to compare and correlate morphological and functional
parameters in pancreatic neuroendocrine tumors (pNET) and their synchronous liver …

Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment

J Assouline, R Cannella, G Porrello… - Radiology: Imaging …, 2023 - pubs.rsna.org
Purpose To investigate whether liver enhancing tumor burden (LETB) assessed at contrast-
enhanced CT indicates early response and helps predict survival outcomes in patients with …

Magnetic resonance imaging may be able to identify the origin of neuroendocrine tumor liver metastases

M Barat, P Soyer, F Al Sharhan, B Terris, A Oudjit… - …, 2021 - karger.com
Objectives: The aim of the study was to discriminate hepatic metastases from pancreatic
neuroendocrine tumors (pNET) and hepatic metastases from midgut neuroendocrine tumors …

Analysis of tumor burden as a biomarker for patient survival with neuroendocrine tumor liver metastases undergoing intra-arterial therapies: a single-center …

M Miszczuk, J Chapiro, D Do Minh… - Cardiovascular and …, 2022 - Springer
Purpose To assess the value of quantitative analysis of tumor burden on baseline MRI for
prediction of survival in patients with neuroendocrine tumor liver metastases (NELM) …